Skip to main content
SpringerLink
Log in

Allgemeine Grundlagen

  • Chapter
Kontrastmittel in der Praxis

  • 42 Accesses

Zusammenfassung

Es wird zwischen negativen (Luft, O2, CO2), positiven wie Barium (BaSO4), Iod (I), paramagnetischen und ultraschallgeeigneten KM in der bildgebenden radiologischen Diagnostik unterschieden. Das erstmals 1896 für Untersuchungen der Peristaltik benutzte Bariumsulfat (BaSO4) geriet schon bald wieder in Vergessenheit. Erst etwa 1 Jahrzehnt später wurde das von Munk (pers. Mitteilung 1950) „neu“ entwickelte BaSO4 als sog. Rieder-Mahlzeit in die Röntgendiagnostik des Magen-Darm-Kanals eingeführt. Hier hat es bis heute in speziellen Abwandlungen, wie z. B. mit verschiedenen Geschmackskorrigenzien, in geänderter Dichte und Molekülgröße seine Stellung halten können, gelegentlich ersetzt durch triiodierte ionische oder nichtionische Röntgenkontrastmittel (RKM), die z. B. bei Verdacht auf Fistel, Ileus oder vielfach bei Kindern indiziert sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Almén T (1969) Contrast agent design. Some aspects on the synthesis of water-soluble agents of low osmolality. J Theor Biol 24: 216–226

    Article  PubMed  Google Scholar 

  2. Binz A, Räth A, von Lichtenberg A (1931) The chemistry of proselectan. Z Urol 25: 297–301

    CAS  Google Scholar 

  3. Grainger RG (1982) Intravascular contrast media — the past, the present and the future. Br J Radiol 55: 1–18

    Article  PubMed  CAS  Google Scholar 

  4. Katajama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175: 621–628

    Google Scholar 

  5. Langecker H, Harwart A, Junkmann K (1954) 3,5-Diacetylamino-2,4,6-trijodbenzoesäure als Röntgenkontrastmittel. Naunyn-Schmiedebergs Arch Exp Pathol 222: 584–590

    CAS  Google Scholar 

  6. Lichtenberg A von, Swick M (1929) Klinische Prüfung des Uroselectans. Klin Wochenschr 8: 2089–2091

    Article  Google Scholar 

  7. Moniz E (1934) L’angiographie cérébrale. Masson, Paris

    Google Scholar 

  8. Osborne ED, Sutherland CG, Scholl AF, Rowntree LG (1923) Roentgenography of urinary tract during excretion of sodium iodide. JAMA 80: 368–373

    Article  CAS  Google Scholar 

  9. Palmer FJ (1988) The RACR survey of intravenous contrast media reactions: final report. Austral Radiol 32: 426–428

    Article  CAS  Google Scholar 

  10. Schrott KM, Behrends B, Clauß W, Kaufmann J, Lehnert J (1986) Iohexol in der Ausscheidungsurographie: Ergebnisse des Drug monitorings. Fortschr Med 7: 53–156

    Google Scholar 

  11. Swick M (1929) Darstellung der Niere und Harnwege im Röntgenbild durch intravenöse Einbringung eines neuen Kontraststoffes, des Uroselectans. Klin Wochenschr 8: 2087–2089

    Article  Google Scholar 

  12. Wallingford VH (1953) The development of organic iodide compounds as X-ray contrast media. J Am Pharmacol Assoc (Sci Ed) 42: 721–728

    Article  CAS  Google Scholar 

  13. Ahlgren P (1973) Long term side effects after myelography with watersoluble contrast media: Conturex, Conray Meglumin 282 and Dimer-X. Neuroradiology 6: 206–211

    Article  PubMed  CAS  Google Scholar 

  14. Ahlgren P (1975) Amipaque myelography. The side effects compared with Dimer X. Neuroradiology 9: 197–202

    Article  PubMed  CAS  Google Scholar 

  15. Ahlgren P (1980) Early and late side effects of water-soluble contrast media for myelography and cisternography: a short review. Invest Radiol 15 (Suppl):S 264-S 266

    Article  Google Scholar 

  16. Battenfeld R (1980) Licht- and elektronenmikroskopische Untersuchungen der osmotischen Nephrose nach Applikation eines Röntgenkontrastmittels. Inaugural Disseration, Tierärztliche Hochschule Hannover

    Google Scholar 

  17. Cigarroa RG et al (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86: 649–652

    Article  PubMed  CAS  Google Scholar 

  18. Chronqvist S (1977) Examination of the subarachnoid space with a water-soluble contrast medium (Amipaque). J Neuroradiol 4: 13–27

    Google Scholar 

  19. Ennis M et al (1989) Histamine release from canine lung and liver mast cells induced by radiographic contrast media. Agents Actions 27: 101–103

    Article  PubMed  CAS  Google Scholar 

  20. Graser C et al (1979) Zur Myelographie mit Metrizamid. Dtsch Med Wochenschr 104: 511–514

    Article  PubMed  CAS  Google Scholar 

  21. Günzel P (1990) Schließen vom präklinischen Experiment auf den Menschen. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4.8, 4. Aufl, 24. Erg Lfg 2 /90. Ecomed, Landsberg

    Google Scholar 

  22. Günzel P (1990) Grundsätzliche Überlegungen zur Durchführung experimenteller toxikologischer Untersuchungen. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4.1, 4. Aufl, 24. Erg Lfg 2 /90. Ecomed, Landsberg

    Google Scholar 

  23. Günzel P, Schöbe) C (1984) Systemische Verträglichkeitsprüfung bei einmaliger Verabreichung - akute Toxizitätsprüfung. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4. 2, 4. Aufl. Ecomed, Landsberg

    Google Scholar 

  24. Günzel P et al (1986) Zur toxikologischen Prüfung von Kontrastmitteln. In: Burger OK et al (eds) Aktuelle Probleme der Biomedizin. Gruyter, Berlin, pp 275–288

    Google Scholar 

  25. Günzel P (1991) Diagnostika (Röntgen-u. a. Kontrastmittel). In: Hess R (eds) Arzneimitteltoxikologie, Anforderungen, Verfahren, Bedeutung. Thieme, Stuttgart, pp 397–404

    Google Scholar 

  26. Hansen EB et al (1978) Late meningeal effects of myelographic contrast media with special reference to metrizamide. Br J Radiol 51: 321–327

    Article  PubMed  CAS  Google Scholar 

  27. Haughton VM et al (1977) Arachnoiditis following myelography with metrizamide in monkeys. Effect of blood in the cerebrospinal fluid. Acta Radiol Suppl 355: 373–378

    PubMed  CAS  Google Scholar 

  28. Hauhgton VM et al (1977) Experimental production of arachnoiditis with water-soluble myelographic media. Radiology 123: 681–685

    Google Scholar 

  29. Haughton VM et al (1977) Arachnoiditis following myelography with water-soluble agents. Radiology 125: 731–733

    PubMed  CAS  Google Scholar 

  30. Haughton VM et al (1978) Comparison of arachnoiditis produced by meglumine locarmate and metrizamide myelography in an animal mdoel. Am J Roentgenol 131: 129–132

    CAS  Google Scholar 

  31. Haughton VM, Ho KC (1980) The risk of arachnoiditis from experimental nonionic contrast media. Radiology 136: 395–397

    PubMed  CAS  Google Scholar 

  32. Haughton VM, Ho KC (1982) Arachnoid responde to contrast media: a comparison of iophendylate and metrizamide in experimental animals. Radiology 143: 699–702

    PubMed  CAS  Google Scholar 

  33. Haughton VM et al (1982) Experimental study of arachnoiditis from iohexol, and investigational nonionic aqueous contrast medium. Am J Neuroradiol 3: 375–377

    PubMed  CAS  Google Scholar 

  34. Haughton VM, Ho KC (1982) Effect of blood on arachnoiditis from aqueous myelographic contrast media. Am J Roentgenol 139 (3): 569–570

    CAS  Google Scholar 

  35. Haughton VM (1985) Intrathecal toxicity of iohexol vs. metrizamide. Survey and current state. Invest Radiol 20 (Suppl 1): S14 - S17

    Article  PubMed  CAS  Google Scholar 

  36. Irstam L, Rosencrantz M (1974) Water-soluble contrast media and adhesive arachnoiditis. Acta Radiol 15: 1–15

    CAS  Google Scholar 

  37. Irstam L (1978) Lumbar myelography with amipaque. Spine 3: 70–82

    Article  PubMed  CAS  Google Scholar 

  38. Irstam L et al (1974) Lumbar myelography and adhesive arachnoiditis. Acta Radiol Diagn 15: 356–368

    CAS  Google Scholar 

  39. Johansen JG et al (1984) Arachnoiditis from myelography and laminectomy in experimental animals. Am J Neuroradiol 5: 97–99

    PubMed  CAS  Google Scholar 

  40. Jorgensen J et al (1975) A clinical and radiological study of chronic lower spinal arachnoidits. Neuroradiology 9: 139–144

    Article  PubMed  CAS  Google Scholar 

  41. Kröpelin T et al (1983) The risk liability of nephrotropic contrast media: clinical and experimental results. In: Taenzer V, Zeitler E (eds) Contrast media in urography, angiography and computerized tomography. Thieme, Stuttgart, pp 129–142

    Google Scholar 

  42. Lang JH et al (1976) Activation of serum complement by contrast media. Invest Radiol 11: 303–308

    Article  PubMed  CAS  Google Scholar 

  43. Lang R (1990) Prüfung auf genotoxische Wirkung. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4.5, 4. Aufl, 24. Erg Lfg 2 /90. Ecomed, Landsberg

    Google Scholar 

  44. Liliequist B, Lundström B (1974) Lumbar myelography and arachnoiditis. Neuroradiology 7: 91–94

    Article  PubMed  CAS  Google Scholar 

  45. McCormick CC et al (1981) Myelography with metrizamide. An analysis of the complications encountered in cervical, thoracic and lumbar myelography. Aust NZ J Med 11: 645–650

    Article  CAS  Google Scholar 

  46. McNeill TW et al (1976) A new advance in water-soluble myelography. Spine 1: 72–84

    Article  Google Scholar 

  47. Moreau JF et al (1980) Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 15 (Suppl 6):S 54-S 60

    Article  Google Scholar 

  48. Muetzel W, Speck U (1983) Tolerance and biochemical pharmacology of iopromide. In: Taenzer V, Zeitler E (eds) Contrast media in Urography, Angiography and Computerized Tomography. Thieme, Stuttgart, New York, pp 11–17

    Google Scholar 

  49. Muetzel W, Speck U (1983) Tolerance and biochemical pharmacology of iopromide. Fortschr Geb Röntgenstr Nuklearmed 118: 11–17

    Google Scholar 

  50. Muetzel W, Speck U (1983) Pharmacochemical profile of iopromide. Am J Neuroradiol 4: 350–352

    PubMed  CAS  Google Scholar 

  51. Müller N et al (1991) Results of a comparative pulmonal tolerance study in the dog following a single intrapulmonal application of three iodine-containing X-ray contrast media (Isovist-300, Ultravist-300, Angiografin). (in press)

    Google Scholar 

  52. Pasaouglu A et al (1988) An experimental evaluation of response to contrast media. Pantopaque, iopamidol, and iohexol in the subarachnoid space. Invest Radiol 23: 762–766

    Article  Google Scholar 

  53. Poggel HA (1984) Reproduktionstoxikologische Untersuchungen. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4. 6, 4. Aufl. Ecomed, Landsberg

    Google Scholar 

  54. Press WR et al (1989) Tolerance to iotrolan after subarachnoid injection in animals. Fortschr Geb Röntgenstr Nuklearmed 128: 126–133

    CAS  Google Scholar 

  55. Scherberich JE et al (1991) Unerwünschte Kontrastmittelwirkungen an der Niere. In: Peters PE, Zeitler E (eds) Röntgenkontrastmittel. Springer, Berlin Heidelberg New York, pp 65–69

    Chapter  Google Scholar 

  56. Schöbel C, Günzel P (1984) Systemische Verträglichkeitsprüfungen bei wiederholter Verabreichung - subakute und chronische Toxizitätsprüfung. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4. 3, 4. Aufl. Ecomed, Landsberg

    Google Scholar 

  57. Schöbel C, Siegmund F (1984) Lokale Verträglichkeitsprüfungen. In: Kuemmerle HP et al (eds) Klinische Pharmakologie, Bd 1, 11–2.4. 7, 4. Aufl. Ecomed, Landsberg

    Google Scholar 

  58. Schöbel, C, Günzel P (1991) Methoden und Ergebnisse toxikologischer Prüfungen von nichtionischen Röntgenkontrastmitteln. In: Peters PE, Zeitler E (eds) Röntgenkontrastmittel. Springer, Berlin Heidelberg New York, pp 5–7

    Chapter  Google Scholar 

  59. Schmidt RC (1980) Mental disorders after myelography with metrizamide and other water-soluble contrast media. Neuroradiology 19: 153–157

    Article  PubMed  CAS  Google Scholar 

  60. Skalpe IO (1978) Adhesive arachnoiditis following lumbar myelography. Spine 3: 61–64

    Article  PubMed  CAS  Google Scholar 

  61. Skalpe IO (1977) Lumbale Myelographie mit wasserlöslichen Kontrastmitteln (Metrizamid). Akt Neurol 4: 179–183

    Google Scholar 

  62. Slätis P et al (1974) Hyperosmolality of the cerebrospinal fluid as a cause of adhesive arachnoiditis in lumbar myelography. Acta Radiol Diagn 15: 619–629

    Google Scholar 

  63. Tirone P, Boldrini E (1983) Effects of radiographic contrast media on the serum complement system. Arch Toxicol (Suppl 6 ): 37–41

    Article  CAS  Google Scholar 

  64. Grainger RG (1987) Osmolality and osmolality-related side effects. In: Contrast media from the past to the future. Berlin, March 27–28. Thieme, Stuttgart

    Google Scholar 

  65. Katayama H, Tanaka T (1988) Clinical survey of adverse reactions to contrast media. Invest Radiol 23: S 88-S 89

    Article  Google Scholar 

  66. Knoefel PK, Huang KC (1956) The biochemorphology of renal tubular transport: iodinated benzoic acids. J Pharm Exp Ther 117: 307–316

    CAS  Google Scholar 

  67. Mitchell DG, Friedman AC (1985) Viscosity of iodinated contrast agents: significance for peripheral venous injection. J Comput Tomogr 9: 77–78

    Article  PubMed  CAS  Google Scholar 

  68. Morris TW, Kern MA, Katzberg RW (1982) The effects of media viscosity on hemodynamics in selective arteriography. Invest Radiol 17: 70–76

    Article  PubMed  CAS  Google Scholar 

  69. Morris TW, Sahler LG, Fischer HW (1982) Calcium binding by radiopaque media. Invest Radiol 17: 501–505

    Article  PubMed  CAS  Google Scholar 

  70. Nauert CM, Langer M, Mützel W (1989) Hemorrheologic effects of lotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media. Fortschr Geb Röntgenstrahl Nuklearmed Suppl 128: 40–45

    CAS  Google Scholar 

  71. Speck U (1987) Newer perspectives in contrast media chemistry. In: Parvez Z, Moncada R, Sovak M (eds) Contrast media: biological effects and clinical application, vol 1. CRC Press, Boca Raton

    Google Scholar 

  72. Ackrill P, McIntosh S, Nimmon C et al (1976) A comparison of the clearance of urographic contrast medium sodium diatrizoate by peritoneal and haemodialysis. Clin Sci Med 50: 69–74

    CAS  Google Scholar 

  73. Barnhart JL (1984) Hepatic disposition and elimination of biliary contrast media. In: Sovak M (ed) Radiocontrast agents. Springer, Berlin Heidelberg New York, pp 367–418

    Chapter  Google Scholar 

  74. Bennett PN, Bath FRCP (1988) Drugs and human lactation. Elsevier, Amsterdam

    Google Scholar 

  75. Choyke PL, Austin AH, Frank JA et al (1992) Hydrated clearance of gadoliniumDTPA as a measurement of glomerular filtration rate. Kidney Int 41: 1595–1598

    Article  PubMed  CAS  Google Scholar 

  76. Corradi A, Menta R, Cambi V et al (1990) Pharmacokinetics of iopamidol in adults with renal failure. Arzneimittelforschung/Drug Res 40 (II): 830–832

    CAS  Google Scholar 

  77. Effersoe H, Rosenkilde R, Groth S et al (1990) Measurement of renal function with iohexol or a comparison of iohexol, 99Tc-DTPA, and 2+Cr-EDTA clearance. Invest Radiol 25: 778–782

    Article  PubMed  CAS  Google Scholar 

  78. Kierdorf H, Kindler J, Winterscheid R et al (1989) Elimination of the nonionic contrast medium iopromide in end-stage renal failure by haemodialysis. In: Taenzer V, Wende S (eds) Recent developments in nonionic contrast media. Thieme, Stuttgart New York, pp 119–123

    Google Scholar 

  79. Lackner K, Krahe T, Götz R, Haustein J (1990) The dialysability of gadoliniumDTPA. In: Bydder G, Felix R, Büchler E et al (eds) Contrast media in MRI. Medicom Europe, Bussum, pp 321–326

    Google Scholar 

  80. Lim KL, Stark DD, Leese PT et al (1991) Hepatobiliary MR imaging: first human exerience with MnDPDP. Radiology 178: 79–82

    PubMed  CAS  Google Scholar 

  81. Lin KS, Moss AA, Riegelmann S (1979) Kinetics of drug-drug interactions: biliary excretion of iodoxamic acid and iopanoic acid in rhesus monkeys. J Pharm Sci 68: 1430–1433

    Article  PubMed  CAS  Google Scholar 

  82. Mützel W, Nagel R, Kemper JD, Clauß W (1984) Pharmakokinetik des nichtionischen Röntgenkontrastmittels Iohexol. Akt Urol 15: 154–156

    Article  Google Scholar 

  83. Schmiedl U, Maravilla KR, Gerlach R, Dowling CA (1990) Excretion of gadopentetate dimeglumine in human breast milk. AJR 154: 1305–1306

    PubMed  CAS  Google Scholar 

  84. Schuhmann-Giampieri G, Krestin G (1991) Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest Radiol 26: 975–979

    Article  PubMed  CAS  Google Scholar 

  85. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR et al (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183: 59–64

    PubMed  CAS  Google Scholar 

  86. Speck U, Mützel W, Herz-Hübner U, Siefert HM (1978) Pharmakologie der Iotroxinsäure eines neuen intravenösen Cholegraphikums. Arzneimittelforschung/Drug Res 28 (II): 2143–2149

    CAS  Google Scholar 

  87. Taenzer V, Speck U, Wolf R (1977) Pharmakokinetik and Plasmaeiweißbindung von Iotroxinsäure. Fortschr Röntgenstr 126: 262–267

    Article  CAS  Google Scholar 

  88. Vogl TJ, Pegios W, McMahon C et al (1992) Gadobenate dimeglumine — a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR 158: 887–892

    PubMed  CAS  Google Scholar 

  89. Waaler A, Svaland M, Fauchald P et al (1990) Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 56: 81–85

    Article  PubMed  CAS  Google Scholar 

  90. Weinmann HJ, Laniado M, Mützel W (1984) Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16: 167–172

    PubMed  CAS  Google Scholar 

  91. Wolf KJ, Steidle B, Skutta T, Mützel W (1983) Iopromide. Clinical experience with a new non-ionic contrast medium. Acta Radiol 24: 55–62

    CAS  Google Scholar 

  92. Andrew E (1990) Adverse reactions of x-ray contrast media in pre-registration trials versus post-marketing surveillance (PMS). 2nd international symposium of CM, Osaka, Japan, November 1990

    Google Scholar 

  93. Good clinical practice for trials on medicinal products in the European Community. COMEUR, Brussels, 1990

    Google Scholar 

  94. Katayama H, Yamaguchi K, Kozuka T et al (1990) Adverse reactions to ionic and non-ionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 11: 52–66

    Google Scholar 

  95. Palmer FJ (1989) The Royal Australian College of Radiologists (RACR) survey of reactions to intravenous ionic and non-ionic media. In: Enge I, Edgren J (eds) Patient safety and adverse events in contrast medium examination. Elsevier, Amsterdam, pp 137–141 (Excerpta medica international Congress series, vol 816)

    Google Scholar 

  96. Schrott KM, Behrends B, Clauß W, Kaufmann J, Lchnert J (1986) Lohexol in der Ausscheidungsurographie. Ergebnisse des Drug-monitoring. Fortschr Med 7: 153–156

    Google Scholar 

Download references

Authors
  1. H. J. Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Clauß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Guldbrandsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Dawson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Schöbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Günzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. U. Speck
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Schuhmann-Gampieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. Andrew
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. Alhassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H. P. Bohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Univ. of London, Royal Postgraduate Medical School, Hammersmith Hospital, Ducane Road, W12 OHS, London, England

    Peter Dawson

  2. Klinische Entwicklung Diagnostika, Schering AG, Müllerstraße. 170-178, D-1000, Berlin 65, Deutschland

    Wolfram Clauß

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Maurer, H.J. et al. (1993). Allgemeine Grundlagen. In: Dawson, P., Clauß, W. (eds) Kontrastmittel in der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93540-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93540-4_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56614-4

  • Online ISBN: 978-3-642-93540-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation